BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Orexo: Interim Report Q2 2018

  Zubsolv® continues its strong performance

  July 11, 2018

   · 

  6 min read
• Pharm Country

  Dr. Reddy’s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market

  The Plaquenil® brand and generic had U.S. sales of approximately $215 million MAT for the most recent twelve months ending in May 2018

  July 11, 2018

   · 

  2 min read
• Business

  Thales and Device Authority launch solution to secure the Connected Health industry

  New healthcare IoT solution ensures device and data security for medical devices

  July 11, 2018

   · 

  5 min read
• Forbion Exceeds Target with EUR 270 Million First Close of Its Fourth Life Sciences VC Fund

  Investment focus will be on new drugs and technologies that will truly impact the future of medicine

  July 11, 2018

   · 

  3 min read
• Deals

  EUSA Pharma Announces Sale of Critical Care Business to SERB Pharmaceuticals

  Completes EUSA’s transition into oncology and rare disease-focused biopharmaceutical company

  July 11, 2018

   · 

  3 min read
• Business

  Arcadia Biosciences and Bioceres Welcome Martin Mariani Ventura as General Manager for Verdeca Joint Venture

  Seasoned agribusiness executive to help prepare drought tolerant soybeans for commercial launch

  July 11, 2018

   · 

  5 min read
• Juniper Research: IoT Security Spend to Reach $6 Billion by 2023, Growing 300% from 2018

  Regulation & Growing Business Risk Provides Critical Impetus

  July 11, 2018

   · 

  2 min read
• Drug Development

  Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA

  The meeting with the FDA on the non-clinical and clinical development plans has further defined Achieve’s Phase 3 clinical program and expected future New Drug Application (NDA) submission.

  July 11, 2018

   · 

  5 min read
• Wright Medical Group N.V. Highlights Significant New Product Launches at the American Orthopaedic Foot & Ankle Society (AOFAS) 2018 Annual Meeting

  Company Announces U.S. Launch of PROstep™ Minimally Invasive Surgery System

  July 11, 2018

   · 

  7 min read
• Policy

  TFF Pharmaceuticals Receives Notice of Allowance for New Foundational Patent Broadly Covering Novel Inhaled Dry Powder Drug Delivery Platform

  The patent gives the Company intellectual property protection for the novel drug delivery platform until 2033

  July 11, 2018

   · 

  5 min read